fiasp solution
novo nordisk canada inc - insuline asparte - solution - 100unité - insuline asparte 100unité - insulins
fiasp solution
novo nordisk canada inc - insuline asparte - solution - 100unité - insuline asparte 100unité - insulins
insulin aspart sanofi
sanofi winthrop industrie - insuline asparte - diabète sucré - les médicaments utilisés dans le diabète - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
kirsty (previously kixelle)
biosimilar collaborations ireland limited - insuline asparte - diabète sucré - les médicaments utilisés dans le diabète - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
fiasp ultra-fast-acting flextouch solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
fiasp ultra-fast-acting penfill solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
fiasp ultra-fast-acting solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
fiasp 100 e/ml ultra-fast-acting pumpcart solution injectable en cartouche
novo nordisk pharma ag - insulinum aspartum - solution injectable en cartouche - insulinum aspartum 6.15 mg corresp. insulinum aspartum 100 u., phenolum, metacresolum, glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 6.15 mg. - le diabète sucré - biotechnologika
ceftin - tab 250mg comprimé
glaxosmithkline inc - céfuroxime (céfuroxime axétil) - comprimé - 250mg - céfuroxime (céfuroxime axétil) 250mg - second generation cephalosporins
ceftin - tab 500mg comprimé
glaxosmithkline inc - céfuroxime (céfuroxime axétil) - comprimé - 500mg - céfuroxime (céfuroxime axétil) 500mg - second generation cephalosporins